Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Explore clinical trials studying Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype. Study availability and eligibility vary by location and protocol.

10 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype trial results

Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

NCT05765812

Conditions
Astrocytoma, Astrocytoma, Grade III, Glioblastoma, +17 more
Locations
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • New York University Langone Medical Center New York, United States
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View all 16 locations
View Trial Details
Recruiting

Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)

NCT07111195

Conditions
Astrocytoma, Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, +8 more
Locations
  • Hospital General Universitario Dr. Balmis Alicante, Spain
  • Hopsital Universitari Vall d'Hebron Barcelona, Spain
  • Hospital Clínico Universitario Virgen de la Arrixaca Murcia, Spain
  • Hospital Universitario de Canarias Santa Cruz de Tenerife, Spain
View Trial Details
Recruiting

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

NCT05879367

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, GBM, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Columbia University Medical Center - Herbert Irving Pavilion New York, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Not Yet Recruiting

The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma

NCT07386002

Conditions
Disease Attributes, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Pathologic Processes, +2 more
Locations
  • The Johns Hopkins Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Hualien Tzu Chi Hospital Hualien City, Taiwan
  • Chang Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan
  • Chang Gung Memorial Hospital, Linkou Taoyuan, Taiwan
View Trial Details

Related conditions